Blackberry is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Blackberry.
| Product ID | 36987-1298_dec580ea-73db-4658-9de1-440c19bb42b7 |
| NDC | 36987-1298 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Blackberry |
| Generic Name | Blackberry |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | BLACKBERRY |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| BLACKBERRY | .05 g/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1298 | Blackberry | Blackberry |
| 36987-1299 | Blackberry | Blackberry |
| 36987-1300 | Blackberry | Blackberry |
| 36987-1301 | Blackberry | Blackberry |
| 49288-0054 | Blackberry | Blackberry |
| 54575-353 | BLACKBERRY | blackberry |